Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest AMD Stories

2013-01-14 23:04:19

AMD´s Andrew Feldman, Gary Morgenthaler, The 451 Group Database Expert and Other Industry Leaders to Present at Launch Event Cambridge, MA (PRWEB) January 14, 2013 NuoDB, Inc., a startup offering the industry´s only patented, elastically scalable Cloud Data Management System (CDMS), announced the agenda for its general availability and CDMS Challenge live-streamed event being held January 15, 2013 at 11 AM EST. Anyone may attend the live-streamed launch event by registering here:...

2013-01-07 08:35:07

IRVINE, Calif. and LAS VEGAS, Jan. 7, 2013 /PRNewswire/ -- VIZIO revealed today the latest addition to its family of premium PCs with the VIZIO 11.6" Tablet PC featuring Windows 8. Designed to provide a fully-functional desktop Windows 8 experience, the 11.6" Tablet PC offers the flexibility and versatility of a mobile device, while challenging the very notion of what a traditional tablet can do. VIZIO will be showcasing the 11.6" Tablet PC at the 2013 Consumer Electronics Show (CES) in Las...

2013-01-07 08:35:01

IRVINE, Calif. and LAS VEGAS, Jan. 7, 2013 /PRNewswire/ -- VIZIO announced today its spring 2013 line-up of Windows 8 PCs, equipped with 10-finger capacitive touch displays on every new model. Seamless touchscreen technology and premium entertainment enhancements to the new spring line give users the ideal interactive Windows 8 experience, supported by outstanding picture quality and rich audio. VIZIO will be showcasing select PC models at the 2013 Consumer Electronics Show (CES) in Las...

2012-12-27 08:25:07

NEW YORK, Dec. 27, 2012 /PRNewswire/ -- Ohr Pharmaceutical Inc., a pharmaceutical company dedicated to the clinical development of new drugs for underserved therapeutic needs in large and growing markets, announced today that it has published a letter to shareholders, available on the Company's website, from its Chief Executive officer, Dr. Irach B. Taraporewala, Ph.D. The letter states: Dear Shareholder, I would like to take this opportunity to share the progress we have made in 2012 and...

2012-12-12 23:07:19

A new study published in Investigative Ophthalmology & Visual Science found that between 40 to 50 percent of older adults with visually impairing eye disease limit their activities due to a fear of falling. Vision scientists warn that this protective strategy puts seniors at risk for social isolation and disability. In the paper, "Activity Limitation Due to a Fear of Falling in Older Adults with Eye Disease," researchers report on their examination of patients with age-related macular...

2012-12-06 05:00:08

Balances performance, scalability, and cost effectiveness to help lower total cost of ownership (PRWEB) December 05, 2012 Silicon Mechanics, Inc., a leading manufacturer of rackmount servers, storage, and high-performance computing hardware, announces that that it now offers the new AMD Opteron 6300 Series processors, which deliver superior performance and scalability for virtualized server platforms central to private and public cloud deployments, big data systems, and high-performance...

2012-11-27 04:20:35

TARRYTOWN, N.Y., Nov. 27, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA(®) (aflibercept) Injection has been approved by the European Commission for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD). According to the European Medicines Agency (EMA) approved Summary of Product Characteristics, EYLEA treatment is initiated with one 2 milligram (mg) injection per month for three consecutive months,...

2012-11-15 12:27:22

TORONTO, Nov. 15, 2012 /PRNewswire/ -- In response to the November 11, 2012 press release issued by the American Academy of Ophthalmology (AAO) Task Force on Genetic Testing, ArcticDx Inc. (Arctic) maintains that Macula Risk®, its laboratory developed test (LDT) for AMD, is of the highest standard and proven to add to the accuracy of clinical assessment alone in its intended use of risk stratification for AMD patients. While in general agreement with the Task Force's Recommendations for...

2012-11-12 16:25:47

SAN DIEGO, Nov. 12, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced its wholly-owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), presented results from a study of its RetnaGene AMD laboratory-developed test to predict risk of disease progression during the 2012 Joint Meeting of the American Academy of Ophthalmology and the Asia-Pacific Academy of...

2012-11-08 08:33:35

SARATOGA, Calif., Nov. 8, 2012 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., developer of the first FDA-approved ophthalmic telescope implant indicated to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today it has received a Health Canada Medical Device License to market the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) in Canada. The telescope implant is an integral component of a new patient care program called...